Literature DB >> 16081792

Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type I IFN and stabilization of class I MHC mRNA.

John Kuchtey1, Peter J Chefalo, Reginald C Gray, Lakshmi Ramachandra, Clifford V Harding.   

Abstract

Dendritic cells (DCs) internalize exogenous Ags and process them for cross-presentation by class I MHC (MHC-I) to CD8+ T cells. This processing can occur by transporter for Ag presentation (TAP)-dependent or TAP-independent mechanisms. We observed that CpG DNA enhanced cross-presentation of Ags by Flt-3L-cultured bone marrow-derived murine DCs by a type I IFN (IFN-alphabeta)-dependent mechanism. Myeloid DCs provided cross-presentation function in this system. Both TAP1 knockout and wild-type DCs showed enhanced cross-presentation when treated with CpG DNA at 26 degrees C, demonstrating that TAP is not essential to this regulatory mechanism, although TAP is an important determinant of MHC-I expression. Enhancement of cross-processing by CpG DNA did not involve increased Ag uptake or proteolysis but did correlate with IFN-alphabeta-dependent increases in expression of MHC-I mRNA and protein. Increased MHC-I mRNA levels resulted in part from stabilization of MHC-I mRNA, a novel posttranscriptional mechanism for regulation of MHC-I expression. Thus, a major mechanism by which CpG oligodeoxynucleotide increase cross presentation by DCs appears to be an IFN-alphabeta-mediated increase in MHC-I synthesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081792     DOI: 10.4049/jimmunol.175.4.2244

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Effects of CpG-ODNs on phenotype and function of monocyte-derived dendritic cells in chronic hepatitis B.

Authors:  Xiao-Xing Xiang; Xia-Qiu Zhou; Jun-Xue Wang; Qing Xie; Xiong Cai; Hong Yu; Hui-Juan Zhou
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

2.  Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I.

Authors:  Tiziana Di Pucchio; Bithi Chatterjee; Anna Smed-Sörensen; Sandra Clayton; Adam Palazzo; Monica Montes; Yaming Xue; Ira Mellman; Jacques Banchereau; John E Connolly
Journal:  Nat Immunol       Date:  2008-03-30       Impact factor: 25.606

3.  Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing.

Authors:  Daimon P Simmons; Pamela A Wearsch; David H Canaday; Howard J Meyerson; Yi C Liu; Ying Wang; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2012-02-27       Impact factor: 5.422

4.  CpG-B oligodeoxynucleotides inhibit TLR-dependent and -independent induction of type I IFN in dendritic cells.

Authors:  Yi C Liu; Reginald C Gray; Gareth A D Hardy; John Kuchtey; Derek W Abbott; Steven N Emancipator; Clifford V Harding
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

5.  Mechanisms of antigen presentation to T cells in murine graft-versus-host disease: cross-presentation and the appearance of cross-presentation.

Authors:  Xiaojian Wang; Hongmei Li; Catherine Matte-Martone; Weiguo Cui; Ning Li; Hung Sheng Tan; Derry Roopenian; Warren D Shlomchik
Journal:  Blood       Date:  2011-09-30       Impact factor: 22.113

Review 6.  Post-transcriptional control of the interferon system.

Authors:  Khalid S A Khabar; Howard A Young
Journal:  Biochimie       Date:  2007-02-24       Impact factor: 4.079

7.  NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction.

Authors:  Jeffrey S Miller; Edus H Warren; Marcel R M van den Brink; Jerome Ritz; Warren D Shlomchik; William J Murphy; A John Barrett; Hans Jochem Kolb; Sergio Giralt; Michael R Bishop; Bruce R Blazar; J H Frederik Falkenburg
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-10       Impact factor: 5.742

8.  Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours.

Authors:  Jasper Manning; Marie Indrova; Barbora Lubyova; Hana Pribylova; Jana Bieblova; Jiri Hejnar; Jana Simova; Tana Jandlova; Jan Bubenik; Milan Reinis
Journal:  Immunology       Date:  2007-08-28       Impact factor: 7.397

9.  Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation.

Authors:  Jillian Emmons; W H Davin Townley-Tilson; Kristen M Deleault; Stephen J Skinner; Robert H Gross; Michael L Whitfield; Seth A Brooks
Journal:  RNA       Date:  2008-03-26       Impact factor: 4.942

10.  Coadministration of polyinosinic:polycytidylic acid and immunostimulatory complexes modifies antigen processing in dendritic cell subsets and enhances HIV gag-specific T cell immunity.

Authors:  Kylie M Quinn; Ayako Yamamoto; Andreia Costa; Patricia A Darrah; Ross W B Lindsay; Sonia T Hegde; Teresa R Johnson; Barbara J Flynn; Karin Loré; Robert A Seder
Journal:  J Immunol       Date:  2013-10-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.